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Abstract
Background: Iodide that is essential for thyroid hormone synthesis is actively transported into the thyroid follicular 
cells via sodium/iodide symporter (NIS) protein in vertebrates. It is well known that NIS expression in thyroid is 
regulated by the thyroid statuses mainly through thyroid stimulating hormone (TSH). Although NIS mRNA expressions 
in extrathyroidal tissues have been qualitatively reported, their regulation by thyroid statuses has not been well 
clarified.
Methods: Male ICR mice aged four weeks were assigned into three groups (control, hypothyroid, and hyperthyroid). 
Hypothyroid group of mice were treated with 0.02% methimazole in drinking water and hyperthyroid group of mice 
received intraperitoneal injection (4 μg L-T4 twice a week) for four weeks. NIS mRNA expression levels in the tissues were 
evaluated using Northern blot hybridization and quantitative real-time RTPCR (qPCR). Additionally, end-point RTPCR for 
the thyroid follicular cell-characteristic genes (TSH receptor, TSHR; thyroid transcription factor-1, TTF1; and paired box 
gene 8, Pax8) was carried out.
Results: By Northern blot analysis, NIS mRNA was detected in thyroid and stomach. In addition to these organs, qPCR 
revealed the expression also in the submandibular gland, colon, testis, and lung. Expression of NIS mRNA in thyroid was 
significantly increased in hypothyroid and decreased in hyperthyroid group. Trends of NIS mRNA expression in 
extrathyroidal tissues were not in line with that in the thyroid gland in different thyroid statuses. Only in lung, NIS mRNA 
was regulated by thyroid statuses but in opposite way compared to the manner in the thyroid gland. There were no 
extrathyroidal tissues that expressed all three characteristic genes of thyroid follicular cells.
Conclusions: NIS mRNA expression in the thyroid gland was up-regulated in hypothyroid mice and was down-
regulated in hyperthyroid mice, suggesting that NIS mRNA in the thyroid gland is regulated by thyroid statuses. In 
contrast, NIS mRNA expression in extrathyroidal tissues was not altered by thyroid statuses although it was widely 
expressed. Lack of responsiveness of NIS mRNA expressions in extrathyroidal tissues reemphasizes additional functions 
of NIS protein in extrathyroidal tissues other than iodide trapping.
Background
Thyroid hormone plays a central role in determining the
levels of thermogenesis and basal metabolism. The
sodium-iodide symporter (Na+/I- symporter, NIS) plays
pivotal role in iodide condensation that is an indispens-
able step in the biosynthesis of the thyroid hormone. NIS
cDNA has been cloned in various species including rat
[1], human [2] and mouse [3]. Physiological importance
of NIS was confirmed by the identification of NIS muta-
tions in patients who had congenital hypothyroidism due
to lack of iodide transport [4,5].
Regulation of NIS mRNA in the thyroid follicular cells
has been investigated both in vivo and in vitro. Levy et al.
showed that NIS protein was drastically increased in
hypothyroid rats [6]. They also demonstrated that that
up-regulation of NIS expression was diminished by hypo-
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physectomy and that thyroid stimulating hormone (TSH)
administration restored NIS expression. Saito et al. also
showed that NIS activity was increased by TSH or forsko-
lin in primary cultured human thyroid cells [7]. These
results clearly demonstrated that cAMP/PKA pathway
provoked by TSH/TSH receptor (TSHR) plays an essen-
tial role in control of NIS expression in thyroid.
Several transcription factors have been shown to play
an important role in thyroid-specific expression of NIS.
Endo et al. demonstrated that thyroid transcription fac-
tor-1 (TTF1), alternatively known as Nkx2-1 (homeobox
protein Nkx2-1), activates the promoter activity of rat
NIS gene [8]. Ohno et al. showed that paired box gene 8
(Pax8) binds and activates upstream enhancer in rat NIS
gene [9].
Interestingly, NIS gene is expressed in a wide range of
extrathyroidal tissues, including mammary gland, colon,
ovary, [10], salivary glands, and gastric mucosa [11].
Among those NIS-positive tissues, the active iodide
transport via NIS protein has been confirmed in salivary
glands, gastric mucosa, lactating mammary gland, and
intestine [12-14].
Not only the normal tissues, but also certain types of
cancer cells are expressing NIS. For example, NIS mRNA
is detected in most thyroid cancer specimens [15].
Besides thyroid cancer cells, NIS is predominantly
expressed intracellularly in many other carcinomas
including breast cancer, lung cancer, salivary gland can-
cer, colon cancer, prostate cancer, and stomach cancer
etc. [16].
As mentioned above, NIS expression and its regulation
were well studied in normal thyroid cells. However, quan-
titative analysis of NIS mRNA and transcriptional regula-
tion of NIS  gene by thyroid statuses in extrathyroidal
tissues have not been explored. Therefore, in the present
study, we analyzed expression of NIS mRNA in various
tissues in different thyroid statuses.
Methods
Animal experiments
M a l e  I C R  m i c e  a g e d  f o u r  w e e k s  w e r e  o b t a i n e d  f r o m
Japan SLC, Inc. (Japan) and randomly divided into three
gr o u ps.  T h r ee  o r  f o u r  m i c e  w e r e  h o us ed  i n  ea c h  ca g e
under controlled conditions of temperature and light.
Mice in hyperthyroid group (n = 7) were intraperitoneally
injected with solution containing 4 μg L-thyroxine (L-T4)
twice a week. Mice in control group (n = 7) and hypothy-
roid group (n = 7) were injected with vehicle twice a
week. Mice in hypothyroid group were given 0.02% meth-
imazole as drinking water and the other mice were given
regular tap water. Treatment was continued for four
weeks until all the mice were sacrificed. Tissues (the thy-
roid gland, submandibular gland, pituitary, lung, liver,
stomach, colon, testis, and pancreas) were immediately
frozen after the dissection and stored at -80°C. Dissection
of small organs (the thyroid gland, pituitary) was per-
formed under the dissecting microscope (Stereomicro-
scope SZX7, Olympus, Tokyo, Japan). All the
e x p e r i m e n t s  w e r e  c a r r i e d  o u t  i n  a c c o r d a n c e  w i t h  t h e
principles and procedures outlined by the Committee for
Animal Experiment of Nagoya University School of Med-
icine and Research Institute of Environmental Medicine.
RNA isolation and cDNA synthesis
Total RNA was isolated from approximately 50 mg frozen
tissue by using TRIzol (Invitrogen, Carlsbad, CA) accord-
ing to the manufacturer's protocol. Extracted RNA sam-
ples were treated with DNase (Qiagen, Valencia, CA),
followed by purification using RNeasy Mini kit (Qiagen).
500 ng RNA of each sample was reverse-transcribed in 20
μl reaction volume using ReverTra Ace (Toyobo Co.,
LTD., Japan), and the cDNA samples were diluted 20-
times with nuclease-free water for both end-point
RTPCR and quantitative real-time RTPCR (qPCR).
Gene expression analyses
Northern blot analysis was done according to the proto-
col described previously in detail [17]. For both end-point
RTPCR and qPCR, 25 ng purified RNA-equivalent cDNA
was used as a template. End-point RTPCR was performed
with GeneAmp PCR system 9700 (Applied Biosystems,
Warrington, UK) and Blend Taq (Toyobo) using a pro-
gram: 94°C for 2 min, [94°C for 10 sec, 60°C for 40 sec] ×
35 cycles, 72°C for 7 min. PCR products were separated
on 2% agarose gel and visualized with ethidium bromide.
qPCR was performed with the ABI-PRISM 7000
Sequence Detector System (Applied Biosystems) and
Power SYBR Green (Applied Biosystems) using a pro-
gram: 95°C for 3 min, [95°C for 10 sec, 60°C for 40 sec] ×
40 cycles. Expression of each target gene was measured in
duplicate and was normalized relative to 18S ribosomal
RNA expression. Primers for the qPCR of mouse NIS
gene were 5'-AGCAGGCTTAGCTGTATCCC-3' (for-
ward) and 5'-AGCCCCGTAGTAGAGATAGGAG-3'
(reverse) to yield 235 bp products. Mouse 18S ribosomal
RNA was measured as an internal control using following
primers: 5'-GTAACCCGTTGAACCCCATTCGTGATG-
3' (forward) and 5'-CGATCCGAGGGCCTCACTA-3'
(reverse) to yield 172 bp. Likewise, the end-point RTPCR
were done using following primers: for TSH receptor
(TSHR), 5'-CTGCGGGGCAAAGAGTGTGC-3' (for-
ward) and 5'-AGGGGAGCTCTGTCAAGGCA-3'
(reverse) to yield 325 bp; for thyroid transcription factor-
1 (TTF1), 5'-ATCTGAGCTGGGGTGCTGGG-3' (for-
ward) and 5'-GCCCTGTCTGTACGCTGCGA-3'
(reverse) to yield 244 bp; for paired box gene 8 (Pax8), 5'-
CGGCGATGCCTCACAACTCG-3' (forward) and 5'-
CCGGATGCTGCCAGTCTCGT-3' (reverse) to yield 221Harun-Or-Rashid et al. Thyroid Research 2010, 3:3
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bp. Gene accession numbers for the genes dealt in this
paper are as follows: mouse NIS  (sodium/iodide sym-
porter), also known as Slc5a5  (solute carrier family 5,
member 5) gene, NM_053248; mouse 18S (18S ribosomal
RNA), NR_003278; mouse TSHR  (thyroid stimulating
hormone receptor), NM_011648; mouse TTF1 (thyroid
transcription factor-1), also known as Nkx2-1 (homeobox
protein Nkx2-1), NM_009385 and Pax8 (paired box gene
8), NM_011040.
Statistical analysis
Values of qPCR were expressed as mean ± SEM and were
analyzed using unpaired t-test. A p value of < 0.05 was
considered significant. All the qPCR experiments were
repeated for at least three times, using at least three ani-
mals per group. Statistical analysis was done using Stat-
view 5.0 (SAS institute Inc., Cary, NC).
Results
NIS mRNA expression in the thyroid gland and 
extrathyroidal tissues
To determine the distribution of NIS mRNA expression
in control mice, qPCR was performed using RNA
extracted from collected tissues and gene specific prim-
ers. Sample without cDNA was used as a negative con-
trol. The relative levels of NIS mRNA expression were as
follows in descending order: stomach, thyroid, subman-
dibular gland, colon, testis, and lung. Abundance of stan-
dardized NIS expression in stomach was as large as that
in the thyroid gland (Figure 1).
To analyze the effects of thyroid statuses on NIS
expression, we compared NIS mRNA expression in mice
under three different thyroid statuses using Northern
blot and qPCR. Northern blot analysis showed drastic
changes of NIS mRNA expression in thyroid but not in
stomach (Figure 2A). We also analyzed TSHβ  mRNA
expression in pituitary by qPCR and confirmed that
TSHβ mRNA was up-regulated in hypothyroid group and
down-regulated in hyperthyroid group (data not shown).
To further quantify NIS  mRNA expression in thyroid,
qPCR was performed and statistically significant differ-
ences among control, hyperthyroid, and hypothyroid
groups were confirmed in thyroid but not in stomach
(Figure 2B). We then analyzed expression of NIS mRNA
in extrathyroidal tissues using qPCR. Among NIS mRNA
positive extrathyroidal tissues, no significant up- or
down-regulation was observed in submandibular gland,
colon, and testis (Figure 3A, B, and 3C). Although the
expression levels were very low, NIS mRNA expression in
lung was significantly suppressed in hypothyroid group
compared with control group (Figure 3D).
Expression of TSHR, TTF1 and Pax8 mRNA in the 
extrathyroidal tissues
To probe the reason why no extrathyroidal tissues
responded to thyroid statuses like thyroid, we added our
study with profiling of genes that are considered charac-
teristic to the thyroid follicular cells. We carried out end-
point RTPCR for thyroid stimulating hormone receptor
(TSHR), thyroid transcription factor-1 (TTF1, also
Figure 1 Comparative tissue distributions of NIS mRNA. NIS mRNA 
levels were estimated by quantitative real-time RTPCR (qPCR) experi-
ments and standardized in respect to 18S mRNA expression. Data are 
presented as a percentage of the value obtained for thyroid gland. 
'SubG' in the panel stands for the submandibular gland.
Figure 2 NIS mRNA regulation in different thyroid statuses in NIS 
abundant tissues. A. Expression of NIS mRNA through Northern blot 
analysis. Total RNA (8 μg for thyroid and 15 μg for stomach) from ani-
mals under different thyroid statuses was loaded on 0.8% agarose gel, 
transferred to the Nylon membrane and hybridized to a 32P-labeled NIS 
specific DNA probe (upper lane). The same membrane used in the up-
per lane was rehybridized to 18S probe to validate the consistency of 
loaded amount of RNA. B. Expression of NIS mRNA through quantita-
tive real-time RTPCR (qPCR). 25 ng purified RNA-equivalent cDNA was 
amplified in one reaction. Expression of each target gene (thyroid, left 
panel; stomach, right panel) was measured in duplicate and was nor-
malized relative to 18S ribosomal RNA expression. Results are shown as 
mean ± SEM. * P < 0.05 compared with control (unpaired t-test). Con-
trol, C; hypothyroid, L; and hyperthyroid, H.
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known as homeobox protein NKx2-1), and paired box
gene 8 (Pax8) using gene specific primers. While TSHR
showed relatively broad mRNA expression in tested
extrathyroidal tissues, expression of TTF1  mRNA was
observed only in the lung, and no tissue was observed to
express Pax8 mRNA (Figure 4).
Discussion
In the present study, we analyzed expression levels of NIS
mRNA in differential thyroid statuses in the mice
extrathyroidal tissues for the first time. NIS  mRNA
expression in various mouse tissues has been analyzed by
Perron et al. using densitometry of band images of end-
point RTPCR product [3]. Our results are, in general, in
agreements with their findings except for lung, for which
very low but significant expression levels could be
detected by qPCR in the present study.
We analyzed effect of thyroid statuses on NIS mRNA
expression in mouse extrathyroidal tissues, and demon-
strated that NIS mRNA in extrathyroidal tissues is regu-
lated in a differential manner from that in thyroid. Our
findings agree well with Brown's old remark in 1961 that
unlike the thyroid gland, however, these extrathyroidal
iodide-concentrating mechanisms have not been shown
to respond to such procedures as hypophysectomy and
thyroxine or TSH administration not only in rodents but
in many vertebrates [18]. More recent paper pointed that
iodide accumulation is not regulated by TSH in extrathy-
roidal tissues in rat [12].
Therefore, NIS protein in extrathyroidal tissues is
unlikely to play important role in the thyroid hormone
Figure 4 Profiling of mRNA expression of thyroid follicular cell-
characteristic genes. End-point RTPCR was performed using cDNA 
from the thyroid gland and the extrathyroidal tissues using specific 
primers for thyroid stimulating hormone receptor (TSHR), thyroid tran-
scription factor-1 (TTF1) and paired box gene 8 (Pax8). 'SubG' in the 
panel stands for the submandibular gland.
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tuses was performed in the same way as in Figure 2B using extrathyroidal tissues including submandibular gland (A), colon (B), testis (C), and lung (D). 
Results are shown as mean ± SEM. * P < 0.05 compared with control (unpaired t-test). Control, C; hypothyroid, L; and hyperthyroid, H.
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homeostasis, and physiological role of extrathyroidal NIS
remains to be elucidated. Yet, extrathyroidal tissues: sali-
vary glands, gastric mucosa, lactating mammary gland,
choroid plexus, and the ciliary body of the eye; are
reported to actively accumulate iodide through NIS [19].
While no extrathyroidal tissues have the ability to organ-
ify the iodide, role of NIS protein in extrathyroidal tissues
may be to pool or to transfer the iodide. Another possible
role of NIS protein is to transport molecules other than
iodide. Due to the similarity in size and charge to iodide,
thiocyanate or other anions are translocated in extrathy-
roidal tissues [19].
Only in lung, in which most feeble signals of NIS
mRNA were detected, NIS mRNA was regulated in the
opposite manner as that in the thyroid gland. Intrigu-
ingly, iodide has been used to thin mucus secretions in
the respiratory tract as an expectorant drug for asthma or
other pulmonary diseases [20]. It was also found that
orally administered radio-iodide reaches bronchial lumen
[21]. This transport of iodide across the bronchial
mucosa may be conducted by NIS. Although we found
thyroid follicular cell-characteristic gene, TTF1 mRNA
expression in lung, there is no evidence to prove the cel-
lular co-localization of NIS and TTF1 until a sensitive
histological assay will be developed. As our NIS mRNA
detection system using qPCR is extremely sensitive, this
result may not mean the existence of functioning NIS
protein in lung. Further investigation especially regarding
t he distribution of NIS positive ce lls in lung would be
required to find physiological functions of NIS in lung. In
addition, proper animal model (i.e. NIS null mice) would
be helpful for the further understanding of functional role
of NIS protein in the extrathyroidal tissues.
To offer a rationale for general lack of responsiveness to
thyroid statuses in extrathyroidal NIS  mRNA, we per-
formed end-point RTPCR for TSHR,  TTF1, and Pax8
mRNA. Table 1 shows, TSHR  mRNA levels were the
highest in thyroid. However, at low level, TSHR mRNA
seems ubiquitously among tested tissues. On the other
hand,  TTF1 and Pax8  mRNA seem more thyroid-spe-
cific. Especially, Pax8 was expressed only in thyroid in
this study. Lacks of TTF1 and/or Pax8 mRNA expression
are likely the cause of insensitivity to thyroid status. We
found that thyroid was the only tissue to express all the
three genes, which may explain the strong NIS mRNA
expression and tight regulation by thyroid statuses. To
clarify the mechanism of NIS mRNA regulation and to
know the physiological reason of its existence in extrathy-
roidal tissues, further investigation would be required.
Conclusions
In this study, we carried out quantitative analysis of NIS
mRNA in extrathyroidal tissues in different thyroid sta-
tuses for the first time to demonstrate that thyroid is the
only tissue in which NIS mRNA level is inversely corre-
lated with thyroid statuses, while NIS  gene is widely
expressed in extrathyroidal tissues. Absence of hypothy-
roidism-derived up-regulation and hyperthyroidism-
derived down-regulation of NIS mRNA in extrathyroidal
tissues seems to serve the purpose to concentrate iodide
resource in thyroid tissue. Extrathyroidal NIS  mRNA
does not seem to be involved in iodide homeostasis.
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